Incidence and prophylaxis of herpes zoster in relapsed or refractory B-cell lymphoma patients after CD19-specific CAR-T cell therapy.

The introduction of CD19-targeted chimeric antigen receptor engineered T-cell (CAR-T) has contributed to the remarkable advances of the treatment for patients with relapsed or refractory (R/R) B-ce...